SCHEMBL4905500

SCHEMBL4905500

CCN(Sc1nc(-c2ccccc2)cs1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
GFER P55789 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
HTR7 P34969 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
MCL1 Q07820 1/20 0.36
RORC P51449 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901805 0.91 TSHR (0.44) NPC1RAB9ATDP1GFERSMN1; SMN2
SCHEMBL4906794 0.90 NPC1 (0.42) NPC1RAB9ATDP1GFERSMN1; SMN2
SCHEMBL4905834 0.83 MAPT (0.39) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4902449 0.83 TSHR (0.44) NPC1RAB9ATDP1GFERSMN1; SMN2
SCHEMBL4900796 0.82 MEN1 (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4905491 0.77 RAB9A (0.45) NPC1RAB9ATDP1SMN1; SMN2HTR1A
SCHEMBL4899670 0.76 PPARA (0.46) SMN1; SMN2
SCHEMBL4902616 0.74 RXFP1 (0.37) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4905853 0.72 ALDH1A1 (0.37) RAB9ASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4904126 0.72 ALDH1A1 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885TDP1 3653/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885TDP1 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.